スマート糖尿病管理の市場規模、シェア、成長分析：デバイスタイプ別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

スマート糖尿病管理の世界市場規模は2023年に60億4,000万米ドルと評価され、2024年の69億3,000万米ドルから2032年には207億5,000万米ドルに成長し、予測期間（2025-2032年）のCAGRは14.7%で成長する見通しです。

スマート糖尿病管理市場は、ヘルスケア技術の進歩や個別ケアの重視によって大きな成長を遂げています。この市場拡大の背景には、糖尿病管理に対する意識の高まり、世界の糖尿病人口の増加、革新的なモニタリング・治療ツールに対する需要があります。メーカーやヘルスケアプロバイダーは、糖尿病患者の生活の質を向上させ、より良い疾患管理を促進し、合併症を最小限に抑えるために、スマートデバイス、ウェアラブル、モバイルアプリケーションの開発に注力しています。さらに、人工知能とデータ解析の導入は、よりオーダーメイドで効果的な糖尿病治療の機会を提供します。健康とウェルネスがますます優先されるようになる中、スマート糖尿病管理市場は、急速に拡大する糖尿病患者集団に革新的なソリューションを提供し、成長軌道を維持する態勢を整えています。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次データと一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• ケーススタディ
• 技術の進歩
• 規制情勢
• スタートアップ分析
• 特許分析

スマート糖尿病管理市場規模：デバイスタイプ別& CAGR（2025-2032）

• 市場概要
• 持続血糖モニタリングシステム
• スマートインスリンペン
• スマートインスリンポンプ
• スマート血糖値測定器
• その他

スマート糖尿病管理市場規模：デバイスタイプ別& CAGR（2025-2032）

• 市場概要
• ハンドヘルド
• ウェアラブル

スマート糖尿病管理市場規模：用途別& CAGR（2025-2032）

• 市場概要
• 1型糖尿病
• 2型糖尿病
• 妊娠糖尿病
• その他

スマート糖尿病管理市場規模：エンドユーザー別& CAGR（2025-2032）

• 市場概要
• 病院
• 在宅ケア
• 専門クリニック
• その他

スマート糖尿病管理市場規模：地域別& CAGR（2025-2032）

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 市場の最近の動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 会社概要
  • 製品ポートフォリオ分析
  • セグメント別シェア分析
  • 収益の前年比比較（2022-2024）

主要企業プロファイル

• Abbott Laboratories（United States）
• Dexcom, Inc.（United States）
• Medtronic plc（Ireland）
• Insulet Corporation（United States）
• F. Hoffmann-La Roche Ltd.（Switzerland）
• Bayer AG（Germany）
• Ascensia Diabetes Care Holdings AG（Switzerland）
• Tandem Diabetes Care, Inc.（United States）
• LifeScan, Inc.（United States）
• AgaMatrix, Inc.（United States）
• Glooko, Inc.（United States）
• DarioHealth Corp.（Israel）
• One Drop（United States）
• Ypsomed Holding AG（Switzerland）
• ARKRAY, Inc.（Japan）
• ACON Laboratories, Inc.（United States）
• Becton, Dickinson and Company（United States）
• Care Innovations, LLC（United States）
• Health2Sync, Inc.（Taiwan）
• Emperra GmbH E-Health Technologies（Germany）

結論と推奨事項

Global Smart Diabetes Management Market size was valued at USD 6.04 billion in 2023 and is poised to grow from USD 6.93 billion in 2024 to USD 20.75 billion by 2032, growing at a CAGR of 14.7% during the forecast period (2025-2032).

The smart diabetes management market is experiencing significant growth, driven by advancements in healthcare technology and an emphasis on personalized care. This expansion is fueled by heightened awareness of diabetes management, a rising global diabetic population, and the demand for innovative monitoring and treatment tools. Manufacturers and healthcare providers are focused on developing smart devices, wearables, and mobile applications to improve the quality of life for diabetes patients, facilitating better disease management and minimizing complications. Additionally, the incorporation of artificial intelligence and data analytics presents opportunities for more tailored and effective diabetes care. As health and wellness become increasingly prioritized, the smart diabetes management market is poised to sustain its growth trajectory, offering innovative solutions for a rapidly expanding population of diabetes sufferers.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Smart Diabetes Management market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Smart Diabetes Management Market Segmental Analysis

Global Smart Diabetes Management Market is segmented by Device Type, Application, End User and region. Based on Device Type, the market is segmented into Handheld and Wearable. Based on Application, the market is segmented into Type 1 Diabetes, Type 2 Diabetes, Gestational Diabetes and Other. Based on End User, the market is segmented into Hospitals, Home Care Settings, Specialty Clinics and Other. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Smart Diabetes Management Market

The Global Smart Diabetes Management market is significantly driven by remarkable technological advancements. Innovations in wearable devices, mobile applications, and data analytics tools are enabling individuals living with diabetes to monitor and manage their condition with increased efficiency. These state-of-the-art technologies not only improve the overall user experience but also equip healthcare providers with vital information, facilitating more personalized care and tailored treatment adjustments. As these tools continue to evolve, they promise to enhance the quality of life for diabetes patients while streamlining communication between patients and healthcare professionals, thereby propelling the market's growth and development.

Restraints in the Global Smart Diabetes Management Market

One of the major constraints facing the Global Smart Diabetes Management market is the high cost of implementation and accessibility. The significant initial investments required for advanced diabetes management devices and services create obstacles for individuals with lower incomes or those residing in areas with inadequate healthcare facilities. This lack of accessibility presents a challenge in ensuring that these innovative technologies reach all demographic segments, thereby impeding widespread acceptance and usage. Consequently, the financial burden associated with these smart solutions limits their availability and effectiveness in promoting better diabetes care across diverse populations.

Market Trends of the Global Smart Diabetes Management Market

The Global Smart Diabetes Management market is experiencing significant growth, primarily fueled by the rising prevalence of diabetes worldwide. As the global population ages and sedentary lifestyles proliferate, the incidence of diabetes is climbing, with millions seeking effective management strategies. This expanding patient demographic catalyzes demand for advanced solutions that offer enhanced monitoring and personalized care. Consequently, innovation in smart diabetes management technologies, including connected devices, mobile applications, and telehealth services, is accelerating, transforming traditional approaches. The convergence of healthcare technology and patient-centric solutions is pivotal for addressing the challenges of diabetes management, thus solidifying the market's positive trajectory toward the future.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Case Studies
• Technology Advancement
• Regulatory Landscape
• Startup Analysis
• Patent Analysis

Global Smart Diabetes Management Market Size by Device Type & CAGR (2025-2032)

• Market Overview
• Continuous Glucose Monitoring Systems
• Smart Insulin Pens
• Smart Insulin Pumps
• Smart Glucose Meters
• Other

Global Smart Diabetes Management Market Size by Device Type & CAGR (2025-2032)

• Market Overview
• Handheld
• Wearable

Global Smart Diabetes Management Market Size by Application & CAGR (2025-2032)

• Market Overview
• Type 1 Diabetes
• Type 2 Diabetes
• Gestational Diabetes
• Other

Global Smart Diabetes Management Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals
• Home Care Settings
• Specialty Clinics
• Other

Global Smart Diabetes Management Market Size & CAGR (2025-2032)

• North America (Device Type, Device Type, Application, End User)
  • US
  • Canada
• Europe (Device Type, Device Type, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Device Type, Device Type, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Device Type, Device Type, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Device Type, Device Type, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Dexcom, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insulet Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche Ltd. (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bayer AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ascensia Diabetes Care Holdings AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Tandem Diabetes Care, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LifeScan, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• AgaMatrix, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Glooko, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DarioHealth Corp. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• One Drop (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ypsomed Holding AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ARKRAY, Inc. (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• ACON Laboratories, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Care Innovations, LLC (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Health2Sync, Inc. (Taiwan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Emperra GmbH E-Health Technologies (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations